Amarex is majority owned by NSF circa 2019: "NS
Post# of 148119
"NSF Expands Health Sciences Group With Acquisition of Majority Interest in Amarex CRO
The transaction creates a single access point for medical device and pharma/biotech product developers seeking integrated, expert services throughout the entire product lifecycle."